Practical implications emphasize the need for tailored interventions focusing on enhancing user trust, ensuring ease of use, and addressing concerns related to privacy risks to facilitate wider acceptance and uptake of wearable insulin biosensors in diabetes management. This evidence concerns the gene INS and diabetes mellitus.